¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21
±³À°ÀÏÀÚ : 2022-08-21
±³À°Àå¼Ò : ¿ë»ê ¹é¹ü±è±¸±â³ä°ü  
±³À°ÁÖÁ¦ : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ)
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ÁöÀºÁ¤
¿¬¶ôó : 02-512-5915  
À̸ÞÀÏ : gyncancer@gyncancer.or.kr      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø 3¸¸¿ø, ¿¬ÀÚ/ÁÂÀå/¸¸65¼¼ÀÌ»ó ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 09:40~09:55 Efficacy of single-dose HPV vaccination  ¿À¿µÅÃ(°­¿øÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 09:55~10:00 Discussion  À̽ÅÈ­(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:00~10:15 Prognostic analysis of splenic parenchymal metastasis in advanced ovarian cancer: Does parenchymal metastasis matter?  ±èÁö¿¬(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:15~10:30 Clinical association of red blood cell distribution as prognostic marker in endometrial carcinoma  ÀÌÅ°æ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:30~10:45 Optimal cytoreduction and platinum-free interval affecting the duration of bevacizumab-based maintenance therapy and prognosis in the first platinum-sensitive recurrence of ovarian cancer  ¿À¼öÇö(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:45~11:00 Survival of incidentally found gynecologic cancer patients: multi-center retrospective study  À̼öÁ¤(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:00~11:15 Comparison of minimally invasive versus open surgery in treatment of endometrial cancer with high risk of recurrence  ÀåÁö¼±(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:15~11:30 Clinical implications of ovarian tumor size at diagnosis in patients with mucinous ovarian cancer  ÀÓÇöÁö(¼­¿ïÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 11:30~11:40 Distillation  ÀÌ»êÈñ¹Ú¼ºÅÃ(¿¬¼¼¿øÁÖÀÇ´ëÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:40~12:00 Abdominal and pelvic anatomy for gynecologic oncology surgery  À±º¸¼º(Â÷ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:00~12:20 Radiologic evaluation for resectability of gynecologic cancer: surgeon¡¯s perspective  À̼ºÁ¾(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:20~12:40 The role of lymphadenectomy in the management of gynecologic cancer  ½É½ÂÇõ(°Ç±¹ÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 12:40~12:50 Discussion  ±èÁ¤½Ä(¼øõÇâÀÇ´ëÇѾçÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:50~13:10 My experience of dV cervical cancer  ÃÖöÈÆ(¼º±Õ°üÀÇ´ë) 
½Ä»ç 08-21 ÄÁº¥¼ÇȦ 13:10~14:00 Lunch  () 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:00~14:20 How to easily perform pelvic lymph node dissection: basic anatomy and spaces  ³²ÀºÁö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:20~14:40 Type of radical hysterectomies: from piver-rutledge-smith to present day  ¹Î°æÁø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:40~15:00 Principles and application of surgical staplers and vessel sealers  À̹æÇö(ÀÎÇÏÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 15:00~15:10 Discussion  ÀÌö¹Î(Â÷ÀÇ´ë±¹¸³¾Ï¼¾ÅÍ) 
È޽Ġ08-21 ÄÁº¥¼ÇȦ 15:10~15:40 Coffee break  () 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 15:40~16:00 Liver mobilization for full evaluation and resection of diaphragm  ¼­µ¿ÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:00~16:20 Surgical approach for resection of pelvic sidewall tumors  ±èÈñ½Â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:20~16:40 Splenectomy & distal pancreatectomy: surgical techique and postoperative care  ÀÓ°¡¿ø(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:40~17:00 Shall we do our bowel surgery? (gynecologic oncologist perspective)  ÀÌÀ¯¿µ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 17:00~17:10 Discussion  ±èÀ±È¯ÃÖÇöÁø(ÀÌÈ­ÀÇ´ëÁß¾ÓÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦8ȸ ´ëÇѽŰæ¿Ü°ú º´¿øÇùÀÇȸ Çмú´ëȸ : 2022-08-21
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2022³âµµ ÀÓ»ó³úÆÄ ÇÏ°è ¿öÅ©¼ó : 2022-08-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 18 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 17 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 18 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 21 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 26 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 20 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 13 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 16 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 7 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 18 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 15 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 10 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 14 2024-05-28
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 12 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 33 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷